Form 4 Tracker
Oric Pharmaceuticals, Inc.
ORIC

8 insider filings · Latest: Oct 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 22, 2025Sep 22 8:31 PMJacob Chacko
Proposed Sale
250,000$10.50$2.6M—

View →

Jun 6, 2025Jun 6 8:16 PMDominic Piscitelli
Proposed Sale
60,000$9.00$540.0K—

View →

Dec 16, 2024Dec 17 2:34 AMMultani Pratik S
Proposed Sale
8,850$8.28$73.3K—

View →

Dec 16, 2024Dec 17 2:31 AMChacko Jacob
Proposed Sale
24,660$8.28$204.2K—

View →

Dec 16, 2024Dec 17 2:29 AMPiscitelli Dominic
Proposed Sale
8,851$8.28$73.3K—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 1, 2026Oct 2 9:50 PMRichard A. HeymanDirector
Option Exercise
3,500$1.6026,700(D)

View →

Sep 28, 2026Sep 29 11:16 PMDominic PiscitelliChief Financial Officer
Option Exercise
13,400$4.3678,500(D)

View →

Sep 24, 2026Sep 25 11:59 PMDominic PiscitelliChief Financial Officer
Option Exercise
600$4.3691,900(D)

View →

Aug 26, 2026Aug 28 8:11 PMDominic PiscitelliChief Financial Officer
Option Exercise
77,000$6.00120,000(D)

View →

Jul 24, 2026Jul 28 8:15 PMRichard A. HeymanDirector
Option Exercise
3,500$1.6030,200(D)

View →

Feb 24, 2026Feb 26 9:47 PMDominic PiscitelliChief Financial Officer
Option Exercise
52,000$4.36144,500(D)

View →